Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection.

K. C. Carter, A. J. Baillie, J. Alexander, T. F. Dolan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Relapse occurs in 5–30% of cases of visceral leishmaniasis (Chulay et al., 1983; Sanyal and Arora, 1979). This could be caused either by treatment failure, or because patients become re-infected after successful chemotherapy. As the majority of individuals who acquire Leishmania donovani infections live in endemic areas, it is highly likely that they would be exposed to the parasite again, but what effect chemotheraphy has on the immunity of the host and resistance to re-infection has received little attention. However, it is well known that many of the immunological responses depressed during active infection are increased following chemotherapy. Thus after treatment patients develop positive responses in delayed hypersensitivity skin tests (Manson-Bahr, 1959) and their lymphocytes respond to in vitro Stimulation with specific antigen (Sacks et al., 1987).
LanguageEnglish
Title of host publicationLeishmaniasis
Subtitle of host publicationthe current status and new strategies for control
Place of PublicationBoston
PublisherSpringer Science + Business Media
Pages993-999
Number of pages7
Volume171
ISBN (Print)9781461288626
DOIs
Publication statusPublished - 1989

Publication series

NameNATO-ASI Series A
Volume171

Fingerprint

Leishmania donovani
Liver
Infection
Drug Therapy
Visceral Leishmaniasis
Delayed Hypersensitivity
Skin Tests
Treatment Failure
Immunity
Parasites
Lymphocytes
Antigens
Recurrence
Therapeutics

Keywords

  • visceral leishmaniasis
  • parasite burden
  • mycobacterium bovis
  • challenge infection
  • Muramyl Dipeptide

Cite this

Carter, K. C., Baillie, A. J., Alexander, J., & Dolan, T. F. (1989). Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection. In Leishmaniasis: the current status and new strategies for control (Vol. 171, pp. 993-999). (NATO-ASI Series A; Vol. 171). Boston: Springer Science + Business Media. https://doi.org/10.1007/978-1-4613-1575-9_128
Carter, K. C. ; Baillie, A. J. ; Alexander, J. ; Dolan, T. F. . / Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection. Leishmaniasis: the current status and new strategies for control. Vol. 171 Boston : Springer Science + Business Media, 1989. pp. 993-999 (NATO-ASI Series A).
@inbook{240ba3834a1e435ba8bd3caa906ef048,
title = "Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection.",
abstract = "Relapse occurs in 5–30{\%} of cases of visceral leishmaniasis (Chulay et al., 1983; Sanyal and Arora, 1979). This could be caused either by treatment failure, or because patients become re-infected after successful chemotherapy. As the majority of individuals who acquire Leishmania donovani infections live in endemic areas, it is highly likely that they would be exposed to the parasite again, but what effect chemotheraphy has on the immunity of the host and resistance to re-infection has received little attention. However, it is well known that many of the immunological responses depressed during active infection are increased following chemotherapy. Thus after treatment patients develop positive responses in delayed hypersensitivity skin tests (Manson-Bahr, 1959) and their lymphocytes respond to in vitro Stimulation with specific antigen (Sacks et al., 1987).",
keywords = "visceral leishmaniasis, parasite burden, mycobacterium bovis, challenge infection, Muramyl Dipeptide",
author = "Carter, {K. C.} and Baillie, {A. J.} and J. Alexander and Dolan, {T. F.}",
year = "1989",
doi = "10.1007/978-1-4613-1575-9_128",
language = "English",
isbn = "9781461288626",
volume = "171",
series = "NATO-ASI Series A",
publisher = "Springer Science + Business Media",
pages = "993--999",
booktitle = "Leishmaniasis",
address = "United States",

}

Carter, KC, Baillie, AJ, Alexander, J & Dolan, TF 1989, Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection. in Leishmaniasis: the current status and new strategies for control. vol. 171, NATO-ASI Series A, vol. 171, Springer Science + Business Media, Boston, pp. 993-999. https://doi.org/10.1007/978-1-4613-1575-9_128

Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection. / Carter, K. C.; Baillie, A. J.; Alexander, J.; Dolan, T. F. .

Leishmaniasis: the current status and new strategies for control. Vol. 171 Boston : Springer Science + Business Media, 1989. p. 993-999 (NATO-ASI Series A; Vol. 171).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection.

AU - Carter, K. C.

AU - Baillie, A. J.

AU - Alexander, J.

AU - Dolan, T. F.

PY - 1989

Y1 - 1989

N2 - Relapse occurs in 5–30% of cases of visceral leishmaniasis (Chulay et al., 1983; Sanyal and Arora, 1979). This could be caused either by treatment failure, or because patients become re-infected after successful chemotherapy. As the majority of individuals who acquire Leishmania donovani infections live in endemic areas, it is highly likely that they would be exposed to the parasite again, but what effect chemotheraphy has on the immunity of the host and resistance to re-infection has received little attention. However, it is well known that many of the immunological responses depressed during active infection are increased following chemotherapy. Thus after treatment patients develop positive responses in delayed hypersensitivity skin tests (Manson-Bahr, 1959) and their lymphocytes respond to in vitro Stimulation with specific antigen (Sacks et al., 1987).

AB - Relapse occurs in 5–30% of cases of visceral leishmaniasis (Chulay et al., 1983; Sanyal and Arora, 1979). This could be caused either by treatment failure, or because patients become re-infected after successful chemotherapy. As the majority of individuals who acquire Leishmania donovani infections live in endemic areas, it is highly likely that they would be exposed to the parasite again, but what effect chemotheraphy has on the immunity of the host and resistance to re-infection has received little attention. However, it is well known that many of the immunological responses depressed during active infection are increased following chemotherapy. Thus after treatment patients develop positive responses in delayed hypersensitivity skin tests (Manson-Bahr, 1959) and their lymphocytes respond to in vitro Stimulation with specific antigen (Sacks et al., 1987).

KW - visceral leishmaniasis

KW - parasite burden

KW - mycobacterium bovis

KW - challenge infection

KW - Muramyl Dipeptide

U2 - 10.1007/978-1-4613-1575-9_128

DO - 10.1007/978-1-4613-1575-9_128

M3 - Chapter

SN - 9781461288626

VL - 171

T3 - NATO-ASI Series A

SP - 993

EP - 999

BT - Leishmaniasis

PB - Springer Science + Business Media

CY - Boston

ER -

Carter KC, Baillie AJ, Alexander J, Dolan TF. Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection. In Leishmaniasis: the current status and new strategies for control. Vol. 171. Boston: Springer Science + Business Media. 1989. p. 993-999. (NATO-ASI Series A). https://doi.org/10.1007/978-1-4613-1575-9_128